Rapid Infuser Market to Hit $1,109 Million by 2031: Coherent Market Insights, Inc
Stryker's (SYK) LIFEPAK 35 to Offer Advanced Monitoring System
Stryker Corporation SYK recently announced the launch of its latest device in the market, offering advanced technology, the LIFEPAK 35 monitor/defibrillator.
With 78% Institutional Ownership, Stryker Corporation (NYSE:SYK) Is a Favorite Amongst the Big Guns
Key Insights Significantly high institutional ownership implies Stryker's stock price is sensitive to their trading actions The top 15 shareholders own 51% of the company Insiders have sold recen
BofA Securities Maintains Stryker Corp(SYK.US) With Buy Rating
BofA Securities analyst Travis Steed maintains $Stryker Corp(SYK.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 63.6% and a total average return of 6.4% over the
Stryker's (SYK) Acquisition of Artelon Set to Expand Its Market
Stryker Corporation SYK recently announced that it has entered into a definitive agreement to acquire Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures.
Stifel Sees S&P 500 Dropping 10% With Sticky Inflation Preventing Fed Rate Cuts
Stryker Releases LIFEPAK 35 Monitor/defibrillator
Express News | NYSE Order Imbalance 54509.0 Shares on Buy Side
Stryker Acquires Privately Held Soft Tissue Fixation Products Firm Artelon
Express News | Stryker To Acquire Privately Held Company Artelon; No Terms Disclosed
Express News | Stryker Corp - Stryker and Artelon Will Continue to Operate as Separate Entities and Proceed With Business as Usual Until Transaction Closes
Express News | Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons
Press Release: Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons
Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons KALAMAZOO, Mich.--(BUSINESS WIRE)--June 03, 2024-- Stryke
Express News | Stryker Corp : Goldman Sachs Initiates Coverage With Neutral Rating; Price Target $372
ZTS, SYK, LLY: Which Healthcare Stock Is the Best Buy?
Stryker (SYK) to Launch Gamma4 Hip Fracture System in Europe
Peeling Back The Layers: Exploring Stryker Through Analyst Insights
Ratings for Stryker (NYSE:SYK) were provided by 14 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The following table encapsulates their recent ratings, offeri
Stryker Initiated at Neutral by Goldman Sachs
Stryker Initiated at Neutral by Goldman Sachs
Express News | Goldman Sachs Initiates Coverage On Stryker With Neutral Rating, Announces Price Target of $372
$1000 Invested In Stryker 15 Years Ago Would Be Worth This Much Today
Stryker (NYSE:SYK) has outperformed the market over the past 15 years by 3.14% on an annualized basis producing an average annual return of 15.27%. Currently, Stryker has a market capitalization of $1
No Data